ReviewPLOS digital health2026
Predicting vesicoureteral reflux outcomes using artificial intelligence: A critical appraisal using APPRAISE-AI.
Review in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Personalized Medicine in Pediatric Urology: From Diagnosis to Individualized Risk Assessment.Medical sciences (Basel, Switzerland) · 2026Review
- AI-Supported Prediction of Vesicoureteral Reflux in Children Based on Cystoscopic Configuration of the Ureteric Orifice.Journal of clinical medicine · 2026Article
- Predictive value of ultrasound findings for high-grade vesicoureteral reflux in children: a retrospective cross-sectional study in Saudi Arabia.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vesicoureteral reflux (VUR) is a common congenital urinary tract anomaly in children, associated with recurrent urinary tract infections (UTIs) and long-term sequelae such as renal scarring and chronic kidney disease. Artificial intelligence (AI) has recently emerged as a promising approach for improving VUR diagnosis, prognosis, and treatment stratification. This narrative review identified studies from the AI-PEDURO repository, a living database of AI applications in pediatric urology, most recently updated in June 2024. Eligible studies employed machine learning methods to predict clinically relevant outcomes of VUR or UTI. Seventeen studies met the inclusion criteria, with common applications including VUR grading from voiding cystourethrograms, prediction of UTI recurrence, spontaneous resolution of VUR, and outcomes following antibiotic prophylaxis or endoscopic injection therapy. Neural networks, tree-based algorithms, and support vector machines were the most frequently used approaches. Using the APPRAISE-AI tool, the median overall study quality was moderate, with strengths in clinical relevance and reporting quality, but persistent weaknesses in methodological conduct, robustness, and reproducibility. AI applications in VUR demonstrate strong potential to enhance diagnostic accuracy, personalize treatment, and predict outcomes; however, most published models remain of low to moderate quality. Adoption of standardized reporting frameworks and multi-institutional collaboration will be essential for improving rigour and accelerating clinical translation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.